The stock market experienced quite a bit of volatility during President Donald Trump's first 100 days in office.

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...